TGTX - TG Therapeutics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5339.58M
Enterprise Value 3254.22M
Trailing P/E N/A
Forward P/E 1-2.83
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)2,228.47
Price/Book (mrq)4.73
Enterprise Value/Revenue 31,668.30
Enterprise Value/EBITDA 6-1.68

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Sep 30, 2018

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-99,280.58%

Management Effectiveness

Return on Assets (ttm)-87.49%
Return on Equity (ttm)-198.93%

Income Statement

Revenue (ttm)152.38k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)0.00%
Gross Profit (ttm)152.38k
EBITDA -151.2M
Net Income Avi to Common (ttm)-150.48M
Diluted EPS (ttm)-2.08
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)97.74M
Total Cash Per Share (mrq)1.27
Total Debt (mrq)91k
Total Debt/Equity (mrq)0.13
Current Ratio (mrq)2.73
Book Value Per Share (mrq)0.93

Cash Flow Statement

Operating Cash Flow (ttm)-117.09M
Levered Free Cash Flow (ttm)-61.19M

Trading Information

Stock Price History

Beta (3Y Monthly) 1.77
52-Week Change 3-50.59%
S&P500 52-Week Change 3-6.91%
52 Week High 317.35
52 Week Low 33.32
50-Day Moving Average 34.56
200-Day Moving Average 37.87

Share Statistics

Avg Vol (3 month) 31.21M
Avg Vol (10 day) 31.02M
Shares Outstanding 576.83M
Float 49.12M
% Held by Insiders 111.98%
% Held by Institutions 164.17%
Shares Short (Dec 31, 2018) 410.88M
Short Ratio (Dec 31, 2018) 48.44
Short % of Float (Dec 31, 2018) 416.49%
Short % of Shares Outstanding (Dec 31, 2018) 413.12%
Shares Short (prior month Nov 30, 2018) 410.64M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 256/1
Last Split Date 3Apr 30, 2012